Looks like there is another wildcard in the mix: M
Post# of 85528
(Total Views: 428)
Posted On: 12/26/2019 2:44:56 PM
Re: Almost A Myth #18106
Looks like there is another wildcard in the mix: Merck R&D development leader, Roger Perlmutter.
He is retiring with Frazier. I just came across his name in this article from June:
https://www.bloomberg.com/news/articles/2019-...essor-hunt
He is retiring with Frazier. I just came across his name in this article from June:
https://www.bloomberg.com/news/articles/2019-...essor-hunt
Quote:
But now, Merck is laying the groundwork for his exit, as well as that of its seasoned research and development leader Roger Perlmutter , who is 66. At the same time, sales of Keytruda are beginning to mature, leading some investors to ask where the drug giant’s future growth will come from.
(6)
(0)Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼